Complex Endocrinology

Discover how specialist and primary care collaboration in complex endocrinology can benefit you and your patients.

Questions? Let us know how to reach you.

Improve Access to Complex Care Treatment

Patients with complex medical conditions in New Jersey sometimes wait up to six months to see a specialist.

 

Improve Patient Outcomes

Investing time to learn how to provide specialty treatment to your patients in your primary care office, where they are most comfortable, can improve patient outcomes.

Grow Your Primary Care Practice Capacity

Research shows that providers who attend Project ECHO sessions increase their ability to treat patients and offer community resources and referrals to patients and caregivers. When multiple providers in one practice attend the same or different ECHOs, capacity to treat patients expands exponentially.

How to Participate

Access your ECHO clinics from anywhere, using your computer or mobile device.

  • Register for your Project ECHO of choice
  • 1 AMA PRA Category 1 Credit™ per 60-minute session attended
  • No-charge consultation with a multidisciplinary team of specialists on active cases
  • No homework
  • IT support available

Learning Objectives

After participating in ECHO, providers will be able to:

  • Effectively diagnose complex endocrinology disease states according to evidence-based guidelines
  • Formulate and implement acceptable treatment modalities for complex endocrinology disease states according to evidence-based guidelines
  • Identify and integrate comorbid conditions in complex endocrinology disease state treatment plans according to evidence-based guidelines
  • Identify and conduct appropriate community resource referrals for patients with complex endocrinology disease states and their caregivers

Complex Endocrinology ECHO Session Leaders

Stephen Schneider, MD, Endocrinologist
Louis Amorosa, MD, Endocrinologist
Jackie Plick, APN, Diabetes Educator
Mary Bridgeman, PharmD, Pharmacist
Laura Montenegro, MSW, LSW, Social Worker

Complex Endocrinology ECHO Curriculum

Thursdays 7:30-8:30 am

  • Month 1: Diabetes BLOCK 1 ↓ ↑
    • Week 1: Distinguishing between T1DM and T2DM in the newly diagnosed patient
    • Week 2: Epidemiology and pathogenesis of T1 and T2 DM
    • Week 3: When to send the patient to an endocrinologist
    • Week 4: Psychiatric aspects of diabetes
  • Month 2: Thyroid BLOCK 1 ↓ ↑
    • Week 1: Diagnosis of hyper and hypothyroid disease
    • Week 2: Treatment of hyperthyroidism
    • Week 3: Treatment of hypothyroidism
    • Week 4: Thyroiditis
  • Month 3: Injectables/Insulin BLOCK ↓ ↑
    • Week 1: Initiating insulin for T1DM
    • Week 2: Initiating insulin for T2DM
    • Week 3: Newly available insulin analogues
    • Week 4: New injectable agents for the treatment of diabetes
  • Month 4: Diabetes BLOCK 2 ↓ ↑
    • Week 1: The diabetic foot
    • Week 2: Appropriate goals for glucose in subgroups with diabetes
    • Week 3: Appropriate goals for lipids and blood pressure in subgroups with diabetes
    • Week 4: Diabetic eye disease
  • Month 5: Social Services BLOCK ↓ ↑
    • Week 1: Community resources for patients
    • Week 2: Financial resources for patients in NJ
    • Week 3: How to get the best deal on diabetes drugs
    • Week 4: Insurance and legal issues in diabetes
  • Month 7: Diabetes BLOCK 3 ↓ ↑
    • Week 1: Diabetic neuropathy
    • Week 2: Diabetic kidney disease
    • Week 3: Cardiovascular risk factors in diabetes
    • Week 4: Prevention programs in prediabetes — when to start educating
  • Month 9: Diabetes BLOCK 4 ↓ ↑
    • Week 1: Diabetes and coronary artery disease
    • Week 2: Microvascular complications — neuropathy treatment
    • Week 3: Microvascular complications — retinopathy
    • Week 4: Autonomic dysfunction in diabetes
  • Month 10: Pituitary BLOCK ↓ ↑
    • Week 1: Male hypogonadism
    • Week 2: Diagnosis and treatment of adrenal insufficiency
    • Week 3: Hyperprolactinemia
    • Week 4: Transgender patients
  • Month 11: Diabetes BLOCK 5 ↓ ↑
    • Week 1: Glucose monitoring and diabetes technology
    • Week 2: Standard oral agents in the treatment of T2DM
    • Week 3: Diabetes in adolescents
    • Week 4: Pancreatitis and hypertriglyceridemia in diabetes
  • Month 12: Obesity BLOCK ↓ ↑
    • Week 1: Treatment of obesity with drugs
    • Week 2: Effects of bariatric surgery on diabetes
    • Week 3: Diet and exercise for the obese with T2DM
    • Week 4: Diet and exercise in the T1DM on insulin (CHO counting)

Complex Endocrinology ECHO Financial Disclosure Declarations

The following session leaders have no relevant financial relationships to disclose: Stephen Schneider, MD, Mary Bridgeman, PharmD, Louis Amorosa, MD, Laura Montenegro, MSW, LSW, Jacquelyn Plick, APN

Rutgers RWJMS Project ECHO Planning Committee

Eric Jahn, MD, jahneg@rwjms.rutgers.edu
Brittany Sullivan, MSPH, brittany.sullivan2@rutgers.edu
Kathy Dodsworth-Rugani, PhD, kathy.dodsworth@rutgers.edu
Lisa Leary, MS, ll671@rwjms.rutgers.edu
Rachel Born, PhD, rachel.born@rutgers.edu

Planning Committee Financial Disclosure Declarations

The following planning committee member has relevant financial relationships to disclose: The spouse of Eric Jahn, MD, owns stock in Proctor & Gamble and Johnson & Johnson.

The following planning committee members have no relevant financial relationships to disclose: Kathy Dodsworth-Rugani, PhD, Brittany Sullivan, MSPH, Rachel Born, PhD, Lisa Leary, MS

Accreditation

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
CME

Rutgers Biomedical and Health Sciences designates this live activity a maximum of 24AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Each session is designated for a maximum of one (1) AMA PRA Category 1 Credit™.

CPE

This application-based activity qualifies for 24 contact hours of continuing pharmacy education credit. Each session qualifies for a maximum of one (1) contact hour of continuing pharmacy education credit. Pharmacists should claim only those contact hours actually spent participating in the activity.

CNE

This activity is awarded 24contact hours. (60 minute CH) Each session is awarded a maximum of one (1) contact hour. Nurses should only claim those contact hours actually spent participating in the activity.

Social Work

This program is approved for social work continuing education hours by Rutgers University Behavioral Health Care in accordance with New Jersey administrative code 13:44G-6.4 and recognized by The New Jersey Board of Social Work Examiners. This program is approved for 24 general social work continuing education hours.

Endo CTA